Nitric oxide synthase modulates the antihyperalgesic effect of the NMDA receptor antagonist MK-801 on carrageenan-induced infammatory pain in rats

10Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

The N-methyl-d-aspartate (NMDA) receptor, an ionotropic glutamate receptor, may play a significant role in the development and maintenance of an infammatory pain. Activation of NMDA receptors may cause nitric oxide (NO) release through activation of NO synthase (NOS). MK-801, a noncompetitive NMDA receptor antagonist is commonly used as a neuropharmacological tool. The interaction between MK-801 and NOS in the inflammatory pain has not been evaluated before. We investigated whether MK-801 affects infammatory pain and whether NOS modulates the effect of MK-801. Carrageenan-induced hyperalgesia was evaluated by measuring the withdrawal response to mechanical stimuli, using an electronic version of the von Frey anesthesiometer in Wistar rats. MK-801 given subcutaneously (0.5-20 μg/kg) or intraplantarly (0.1 and 0.15 μg/paw) significantly reduced mechanical hyperalgesia. Intraplantarly given MK-801 exerted a local antihyperalgesic effect, because when applied to the contralateral side it did not reduce mechanical sensitivity in the ipsilateral side. N-nitro-L-arginine methyl ester hydrochloride (5 and 10 mg/kg), a non-selective NOS inhibitor, significantly reduced the effects of MK-801. N-ω-Propyl-L-arginine hydrochloride (0.5-2 mg/kg), a selective inhibitor of neuronal NOS, increased the antihyperalgesic effect of MK-801, whereas S-methylisothiourea (5-15 μg/kg), a selective inhibitor of inducible NOS, lowered the antihyperalgesic effect of MK-801. Importantly, each NOS inhibitor given alone did not affect carrageenan-induced hyperalgesia. In conclusion, MK-801 is effective against inflammatory pain and its antihyperalgesic effect is modulated in a different ways by NOS, being enhanced by a neuronal NOS inhibitor but reduced by an inducible NOS inhibitor.

References Powered by Scopus

Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures

2187Citations
N/AReaders
Get full text

Nitric oxide in the central nervous system: Neuroprotection versus neurotoxicity

1303Citations
N/AReaders
Get full text

Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs

1125Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Evaluation of the anti-inflammatory action of curcumin analog (DM1): Effect on iNOS and COX-2 gene expression and autophagy pathways

24Citations
N/AReaders
Get full text

Renin-angiotensin-aldosterone system: A current drug target for the management of neuropathic pain

11Citations
N/AReaders
Get full text

Inhibition of neuronal and inducible nitric oxide synthase does not affect the analgesic effects of NMDA antagonists in visceral inflammatory pain

10Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Srebro, D. P., Vucković, S. M., Savic Vujovic, K. R., & Prostran, M. S. (2014). Nitric oxide synthase modulates the antihyperalgesic effect of the NMDA receptor antagonist MK-801 on carrageenan-induced infammatory pain in rats. Tohoku Journal of Experimental Medicine, 234(4), 287–293. https://doi.org/10.1620/tjem.234.287

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

50%

Professor / Associate Prof. 2

33%

Researcher 1

17%

Readers' Discipline

Tooltip

Pharmacology, Toxicology and Pharmaceut... 2

33%

Neuroscience 2

33%

Physics and Astronomy 1

17%

Engineering 1

17%

Save time finding and organizing research with Mendeley

Sign up for free